Kantorová Ema, Bittšanský Michal, Sivák Štefan, Baranovičová Eva, Hnilicová Petra, Nosáľ Vladimír, Čierny Daniel, Zeleňák Kamil, Brück Wolfgang, Kurča Egon
Clinic of Neurology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollárova 2, 03659, Martin, Slovak Republic.
Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University in Bratislava, Kollárova 2, 03659, Martin, Slovak Republic.
BMC Cancer. 2017 Jun 19;17(1):424. doi: 10.1186/s12885-017-3415-1.
Co-occurrence of multiple sclerosis (MS) and glial tumours (GT) is uncommon although occasionally reported in medical literature. Interpreting the overlapping radiologic and clinical characteristics of glial tumours, MS lesions, and progressive multifocal leukoencephalopathy (PML) can be a significant diagnostic challenge.
We report a case of anaplastic astrocytoma mimicking PML in a 27-year-old patient with a 15-year history of MS. She was treated with interferon, natalizumab and finally fingolimod due to active MS. Follow-up MRI, blood and cerebrospinal fluid examinations, and biopsy were conducted, but only the latter was able to reveal the cause of progressive worsening of patient's disease.
Anaplastic astrocytoma misdiagnosed as PML has not yet been described. We suppose that the astrocytoma could have evolved from a low grade glioma to anaplastic astrocytoma over time, as the tumour developed adjacent to typical MS plaques. The role of the immunomodulatory treatment as well as other immunological factors in the malignant transformation can only be hypothesised. We discuss clinical, laboratory and diagnostic aspects of a malignant GT, MS lesions and PML. The diagnosis of malignant GT must be kept in mind when an atypical lesion develops in a patient with MS.
多发性硬化症(MS)与胶质肿瘤(GT)同时出现的情况并不常见,尽管医学文献中偶尔有相关报道。解读胶质肿瘤、MS病灶以及进行性多灶性白质脑病(PML)重叠的影像学和临床特征可能是一项重大的诊断挑战。
我们报告一例27岁、有15年MS病史的患者,其间变性星形细胞瘤酷似PML。由于MS病情活跃,她先后接受了干扰素、那他珠单抗治疗,最后使用了芬戈莫德。进行了随访MRI、血液和脑脊液检查以及活检,但只有活检揭示了患者病情逐渐恶化的原因。
尚未有间变性星形细胞瘤被误诊为PML的相关描述。我们推测,随着肿瘤在典型MS斑块附近发展,星形细胞瘤可能随时间从低度胶质瘤演变为间变性星形细胞瘤。免疫调节治疗以及其他免疫因素在恶性转化中的作用只能进行推测。我们讨论了恶性GT、MS病灶和PML的临床、实验室及诊断方面。当MS患者出现非典型病灶时,必须考虑恶性GT的诊断。